FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
758 letters match. Newest first.
-
DrugsEyePoint Pharmaceuticals, Inc.
FDA cited EyePoint Pharmaceuticals in Watertown, MA for manufacturing-quality violations affecting its YUTIQ eye implant, including inadequate investigations and process controls.
High risk -
DrugsEugia Pharma Specialities Limited
FDA cited Eugia Pharma Specialities for CGMP violations at its India sterile injectable plant, including falsified records and contamination risks.
High risk -
AnimalBullyKamp Products LLC
BullyKamp Products LLC marketed unapproved animal drugs with disease-treatment claims on its website, FDA says.
High risk -
AnimalTop Dog Pet Store LLC dba The Bulldog Cartel
Top Dog Pet Store marketed Green Magic and Bulldog Cartel Parvo Combat as unapproved animal drugs for treating diseases.
High risk -
DrugsOmega Tech Labs LLC
Omega Tech Labs in Boise, Idaho, released microbially contaminated combination drug-device product and failed manufacturing rules.
High risk -
DrugsVelocity Pharma LLC
Velocity Pharma distributed eye drop drugs made by contract manufacturers with serious manufacturing and sanitation violations.
High risk -
FoodHigh Quality Organics, Inc.
FDA warned High Quality Organics over ready-to-eat spices after finding weak pathogen controls and no pesticide-hazard reanalysis.
High risk -
TobaccoCavalry Industries d/b/a Select Vape
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
DrugsWalmart, Inc.
FDA warned Walmart over selling an unapproved 90% lactic acid chemical peel drug that can cause burns.
High risk -
DrugsAmazon.com, Inc.
FDA warns Amazon over selling two unapproved chemical peel drugs that can burn skin.
High risk -
DevicesCriticare Technologies, Inc.
FDA warns Criticare Technologies over patient monitors after finding unresolved CAPAs, weak design controls and supplier checks at its Warwick, Rhode Island plant.
High risk -
DrugsBrassica Pharma Pvt. Ltd.
FDA warns Brassica Pharma over fabricated sterility and environmental data and poor aseptic controls for sterile drugs.
High risk -
FoodFormulation Technology, Inc.
FDA warns Formulation Technology over unapproved migraine supplement claims and manufacturing/labeling violations.
High risk -
BiologicsMassachusetts Institute of Technology MIT
FDA says MIT's review board for human research failed to make sure consent forms and meeting records met federal rules.
Medium -
DrugsOptikem International Inc.
FDA warns Optikem International after inspection found inadequate aseptic controls for sterile ophthalmic drugs, including contamination and validation failures.
High risk -
FoodPepsiCo, Inc.
FDA warned PepsiCo after Salmonella Cubana was found at its Danville, Illinois Quaker Oats plant, prompting recalls of granola bars and cereals.
High risk -
FoodChoo's Enterprises Ltd
FDA warns Barbados acidified foods maker Choo's Enterprises over missing scheduled processes for syrups and seasonings.
High risk -
DrugsSun Pharmaceutical Industries Limited
FDA cited Sun Pharmaceutical Industries for inadequate cleaning and maintenance at its Dadra drug plant, risking cross-contamination, and for weak investigations.
High risk -
FoodFrozen Food Development, Inc.
Frozen Food Development packed ready-to-eat frozen produce under rodent activity and lacked required pathogen controls.
High risk -
FoodBimbo Bakeries USA, Inc.
FDA says Bimbo Bakeries USA misbranded Sara Lee and Brownberry bread labels, listing sesame and tree nuts not in the products.
Medium -
BiologicsIndiana Lions Eye Bank, Inc. dba VisionFirst Indiana Lions Eye Bank
Indiana Lions Eye Bank distributed ocular tissue from donors with sepsis after failing to screen them as ineligible.
High risk -
DrugsLandy International
FDA found Landy International’s OTC hand sanitizers adulterated after a 2023 inspection revealed missing testing, unsafe water, and data integrity failures.
High risk -
DrugsAngela D. Ritter, M.D.
FDA warns Dr. Angela Ritter over unauthorized dosing of an investigational drug and missing ethics-board review.
High risk -
BiologicsNeobiosis, LLC
FDA warns Neobiosis over unapproved amniotic fluid and umbilical cord products and serious manufacturing quality failures.
High risk -
AnimalAll Things Bunnies, Inc.
All Things Bunnies markets Toltrazuril 5% Suspension as an unapproved new animal drug for coccidiosis.
Medium -
Animaltotaltoltrazuril.com
FDA warned totaltoltrazuril.com for selling Total Toltrazuril, an unapproved new animal drug, for coccidiosis and horse EPM.
High risk -
AnimalToltrazuril Shop
Toltrazuril Shop sells unapproved toltrazuril animal drugs online for coccidiosis and EPM, FDA says.
High risk -
AnimalLinessa Farms, LLC
Linessa Farms markets unapproved toltrazuril animal drugs for coccidiosis, FDA warns after website review.
High risk -
FoodGenpro Imports & Export Inc.
FDA warns Genpro Imports over missing FSVP records for imported produce and ginger.
Medium -
FoodAmin Trading Agency LLC
FDA found Amin Trading Agency lacked required foreign supplier checks for imported Indian spice products, including Everest and Masala E Magic.
Medium -
DrugsSafari Stem Cell, LLC
FDA warned Safari Stem Cell for selling unapproved stem cell animal drugs made without required CGMP controls, including sterility testing.
High risk -
BiologicsAkan Biosciences, Inc.
FDA warned Akan Biosciences over unapproved Ayama injectable and donor-screening failures.
High risk -
DrugsSeatex, LLC
FDA: Seatex made hand sanitizer on equipment also used for floor cleaner and skipped ingredient identity tests.
High risk -
DrugsGrupo Quimico SRL
FDA warns Uruguay contract testing lab Grupo Quimico over data integrity failures, including unreported failing HPLC results.
High risk -
DrugsSeatex, LLC
Seatex, LLC made OTC hand sanitizer drugs with inadequate current good manufacturing practice (CGMP), including shared equipment with industrial chemicals and missing component testing.
High risk -
DrugsVintage Chemical Inc.
FDA warned Vintage Chemical after an inspection found over-the-counter hand soap and sanitizer made on equipment shared with industrial cleaners.
High risk -
FoodHunan Gagazui Food Co., Ltd.
Hunan Gagazui Food Co., Ltd. processed U.S.-bound low-acid canned surimi soybean snacks outside its filed process and without required retort controls.
High risk -
FoodHi-Pro Feeds, LLC
Hi-Pro Feeds made medicated goat feed linked to goat deaths; FDA cited missing urea hazard controls and late report.
High risk -
DevicesSpectrum Medical Ltd
Spectrum Medical marketed Quantum perfusion devices beyond cleared uses and had corrective-action failures.
High risk -
DevicesP.T. Sankei Medical Industries
FDA warned P.T. Sankei Medical Industries over unapproved changes to its single-use sphygmomanometer and quality system violations.
High risk -
DrugsDr Sankunni’s Ayurvedic Research Foundation Private Ltd.
Dr Sankunni's Ayurvedic Research Foundation failed to correct drug listing and registration errors for its balms and hand sanitizer.
Low -
DrugsC&T Dream Co., Ltd.
C&T Dream failed CGMP (current good manufacturing practice) for its over-the-counter Dry Skin Healing Ointment, including identity testing and process validation.
High risk -
DrugsNatco Pharma Limited
FDA warned Natco Pharma of adulterated drugs after finding dirty equipment and weak investigations at an India plant.
High risk -
DrugsMaster Paints & Chemicals Corp.
FDA warned Master Paints & Chemicals Corp. over inadequate testing and quality oversight for OTC drugs including hand sanitizer.
High risk -
DevicesSoulaire Corporation
FDA says Soulaire marketed an ECP device for unapproved uses without clearance or approval.
High risk -
FoodAppleton City Feed Service LLC
FDA warned Appleton City Feed Service, a Missouri medicated feed mill, of pest, cross-contamination and drug-combination risks in animal feed.
High risk -
DrugsJiangsu Meifan Biotechnology Co. Ltd.
FDA cites Jiangsu Meifan Biotechnology for OTC drug manufacturing-rule failures and import alert.
High risk -
FoodNew India Bazar, Inc.
FDA cites New India Bazar for missing FSVP and allergen hazard analysis after MAGGI noodle recall.
High risk -
DrugsKilitch Healthcare India Limited
FDA warns Kilitch Healthcare India over insanitary sterile drug manufacturing and falsified environmental monitoring data.
High risk -
DrugsAntaria Pty. Ltd.
FDA warned Antaria Pty. Ltd. about manufacturing quality failures in its active drug ingredient, including poor out-of-specification investigations and testing.
High risk